Article
RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes
1 Jan 2014
Abstract excerpt
BACKGROUND: The translocation t(9;11)(p22;q23) leading to the leukemogenic fusion gene MLL-AF9 is a frequent translocation in infant acute myeloid leukemia (AML). This study aimed to identify genes and molecular processes downstream of MLL-AF9 (alias MLL-MLLT3) which could assist to develop new targeted therapies for such leukemia with unfavorable prognosis. METHODS: In the AML cell line THP1 which harbors this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
